Risk-adapted strategy or universal multimodal approach for PONV prophylaxis?
PONV
anaesthesia
antiemetics
nausea
patient satisfaction
postoperative nausea and vomiting
surgery
vomiting
Journal
Best practice & research. Clinical anaesthesiology
ISSN: 1878-1608
Titre abrégé: Best Pract Res Clin Anaesthesiol
Pays: Netherlands
ID NLM: 101121446
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
received:
12
03
2020
revised:
23
04
2020
accepted:
05
05
2020
entrez:
8
12
2020
pubmed:
9
12
2020
medline:
2
6
2021
Statut:
ppublish
Résumé
The issue of postoperative nausea and vomiting (PONV) remains important in surgical practice, contributing to patient distress, slower recovery, and increased use of healthcare resources. Many surgical patients report it to be a worse problem than pain. Numerous findings of research indicate that PONV significantly affects patients' well-being and is among the important determinants of patient satisfaction with perioperative care. Numerous investigations have confirmed the efficacy of combining pharmacological interventions indicating that PONV is a clinical complication that is in principle avoidable. Nonetheless, PONV continues to be bothersome for too many patients. Thus, perhaps the biggest challenge across the field is to achieve a uniformly high standard of PONV management using the currently available resources. Although a risk-adapted approach has been advocated in the past, the current trend incorporated in clinical guidelines support a more liberal approach of multimodal antiemetic prevention. The current article emphasizes pros and cons of the various approaches to PONV prophylaxis and depicts most promising strategies to achieve a "PONV-free hospital."
Identifiants
pubmed: 33288122
pii: S1521-6896(20)30036-7
doi: 10.1016/j.bpa.2020.05.003
pii:
doi:
Substances chimiques
Antiemetics
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
721-734Informations de copyright
Copyright © 2020 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest PK acted as clinical investigator in clinical trials on PONV and received patient-related fees to conduct the studies. He is also the coauthor of the cited consensus statements on PONV published by the Society of Ambulatory Anesthesia (SAMBA) and American Society for Enhanced Recovery (ASER).